A phase i study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation
- 1 January 1984
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 10 (1), 69-76
- https://doi.org/10.1016/0360-3016(84)90414-0
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Radiosensitization of hematopoietic precursor cells (CFUc) in glioblastoma patients receiving intermittent intravenous infusions of bromodeoxyuridine (BUdR)International Journal of Radiation Oncology*Biology*Physics, 1983
- Misonidazole and radiotherapy to treat malignant glioma: A phase II trial of the radiation therapy oncology groupInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Nonlinear pharmacokinetic models for 5-fluorouracil in man: Intravenous and intraperitoneal routesClinical Pharmacology & Therapeutics, 1980
- High‐dose intravenous and hepatic artery infusions of thymidineClinical Pharmacology & Therapeutics, 1978
- Development of a clonogenic cell assay for human brain tumorsCancer, 1978
- Radiation Sensitivity of Cultured Human Glioblastoma CellsRadiology, 1977
- Comparison of Intravenous and Intra-arterial Pyrimidine Infusion as a Means of Radiosensitizing TumorsIn VivoRadiology, 1977
- Clinical testing of the radiosensitiser Ro-07-0582 I. dose tolerance, serum and tumour concentrationsClinical Radiology, 1976
- Radiosensitization of Malignant Brain Tumours with Bromouridine (Thymidine Analogue)Acta Radiologica: Therapy, Physics, Biology, 1969
- GENETICS OF HUMAN CELL LINESThe Journal of Experimental Medicine, 1960